Tapinarof versus betamethasone cream for plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This study tests two different creams for plaque psoriasis, a condition that causes scaly patches on the skin. One cream is newer and the other is a standard steroid cream; researchers want to see which one works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old
- You have plaque psoriasis covering 2% to 20% of your body (mild to moderate)
- You have had psoriasis for at least 6 months
- You are not using other psoriasis treatments, or you can stop them for 2 weeks before starting
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This study tests if a cream called tapinarof can improve skin symptoms in people with chronic or subacute cutaneous lupus erythematosus (CLE). The goal is to see if it reduces redness, scaling, and thickness of active lesions.
This early study tests whether taking vitamin D together with triamcinolone (a steroid used on skin) works better for plaque psoriasis than a standard approach. It aims to see if the combination helps clear psoriasis plaques and is safe.
This study tests a new topical cream for treating mild to moderate plaque psoriasis. It aims to see if the cream is safe and effective for reducing psoriasis symptoms.
This study tests a cream for psoriasis to see if it helps prevent or reduce changes in skin color (dark or light patches) that can happen after psoriasis clears. It may be a good fit if you have medium to dark skin and your psoriasis is stable.
This study tests a new prescription cream called roflumilast to see if it helps with both skin plaques and nail psoriasis. If you join, you'll apply the cream to affected areas and be monitored to see how well it works and if it's safe.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.